DOR/3TC/TDF (doravirine/lamivudine/tenofovir disoproxil fumarate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DOR/3TC/TDF (doravirine/lamivudine/tenofovir disoproxil fumarate), covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI [Phase 4]